It is worth mentioning that we observed an inverse correlation between DRAM1 expression and carmustine (a chemotherapeutic drug recommended by the latest National Comprehensive Cancer Network (NCCN) guidelines for the treatment of glioma) (Figure 11(a)). Here, DRAM1 is linked to central nervous system cancer.